TNDM Insider Trading
Insider Ownership Percentage: 2.20%
Insider Buying (Last 12 Months): $203,312.24
Insider Selling (Last 12 Months): $858,400.00
Tandem Diabetes Care Insider Trading History Chart
This chart shows the insider buying and selling history at Tandem Diabetes Care by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Tandem Diabetes Care Share Price & Price History
Current Price: $18.90
Price Change: ▲ Price Increase of +1.009 (5.64%)
As of 03/12/2025 12:01 PM ET
Tandem Diabetes Care Insider Trading History
Tandem Diabetes Care Institutional Trading History
Data available starting January 2016
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Read More on Tandem Diabetes Care
Today's Range
Now: $18.90
52 Week Range
Now: $18.90
Volume
696,203 shs
Average Volume
1,470,901 shs
Market Capitalization
$1.26 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.45
Who are the company insiders with the largest holdings of Tandem Diabetes Care?
Who are the major institutional investors of Tandem Diabetes Care?
Which institutional investors are selling Tandem Diabetes Care stock?
In the last quarter, TNDM stock was sold by these institutional investors:
- Capital World Investors
- Bellevue Group AG
- Janus Henderson Group PLC
- Divisadero Street Capital Management LP
- Next Century Growth Investors LLC
- First Light Asset Management LLC
- Ameriprise Financial Inc.
- Jefferies Financial Group Inc.
In the last year, company insiders that have sold Tandem Diabetes Care company stock include:
- Kim D Blickenstaff (Director)
- Dick Allen (Director)
Learn More investors selling Tandem Diabetes Care stock.
Which institutional investors are buying Tandem Diabetes Care stock?
Within the last quarter, TNDM stock was acquired by institutional investors including:
- Hood River Capital Management LLC
- Jacobs Levy Equity Management Inc.
- Brown Advisory Inc.
- Park West Asset Management LLC
- Baillie Gifford & Co.
- ArrowMark Colorado Holdings LLC
- GW&K Investment Management LLC
- Stephens Investment Management Group LLC
In the last year, these company insiders have bought Tandem Diabetes Care stock:
- Kim D Blickenstaff (Director)
- Dick Allen (Director)
- Leigh Vosseller (CFO)
- Jean-Claude Kyrillos (COO)
- Kathleen Mcgroddy-Goetz (Director)
- Shannon Marie Hansen (Insider)
Learn More investors buying Tandem Diabetes Care stock.